Screening for Associated Autoimmunity in Children and Adolescents with Type 1 Diabetes Mellitus (T1DM)

被引:75
|
作者
Karavanaki, Kyriaki [1 ]
Kakleas, Kostas [1 ]
Paschali, Evangelia [2 ]
Kefalas, Nikos [3 ]
Konstantopoulos, Ilias [1 ]
Petrou, Vassilis [3 ]
Kanariou, Maria [2 ]
Karayianni, Christina [1 ]
机构
[1] Univ Athens, P&A Kyriakou Childrens Hosp, Dept Pediat B, Diabet Clin, Athens, Greece
[2] Aghia Sophia Childrens Hosp, Dept Immunol & Histocompatibil, Athens, Greece
[3] PA Kyriakou Childrens Hosp, Dept Pediat Endocrinol, Athens, Greece
关键词
Antibodies; organ-specific; Anti-thyroid antibodies; Tissue transglutaminase antibodies; Parietal cell antibodies; Type; 1; diabetes; children with; CELIAC-DISEASE; THYROID AUTOIMMUNITY; TISSUE TRANSGLUTAMINASE; SEX-HORMONES; AUTOANTIBODIES; MULTICENTER; ANTIBODIES; RISK; CELL; AGE;
D O I
10.1159/000201108
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background/Aims: Type 1 diabetes (T1DM) is associated with autoimmune thyroid, celiac, autoimmune gastric and Addison's disease. Our aim was to investigate the prevalence of associated autoantibodies in relation to the demographic and beta-cell autoantibody status (anti-GAD). Methods: Antibodies against thyroid peroxidase (anti-TPO), thyroglobulin (anti-Tg), tissue transglutaminase (anti-tTG IgA), parietal cells (APCA) and adrenal tissue (AAA) were measured in 144 children with T1DM with a mean +/- SD age of 12.3 +/- 4.6 years and a diabetes duration of 4.6 +/- 3.8 years. Results: The prevalence of antibody positivity among our patients was: anti-GAD 53.2%, anti-thyroid (anti-TPO 17.4%, anti-Tg 11.1%); anti-tTG IgA 7.6%, APCA 4.0%, and AAA 0%. Among the children with positive anti- thyroid antibodies, 60% developed autoimmune thyroiditis, while among those anti-tTG IgA positive, 62.5% developed biopsy-confirmed celiac disease. Female gender was more frequent among anti-tTG IgA-positive patients (OR 4.47, p = 0.068), while increasing age was associated with anti-Tg positivity (OR 22.9, p = 0.041). The presence of anti-thyroid antibodies was associated with the presence of anti-GAD (OR 1.45, p = 0.01) and parietal cell antibodies (OR 4.98, p = 0.09). Conclusion: Among T1DM patients, the prevalence rates of anti-thyroid and parietal cell antibodies increased with age and diabetes duration. As the presence of anti-GAD was associated with gastric and thyroid autoimmunity, it could serve as marker for the development of additional autoimmunity in adolescents with diabetes. Copyright (C) 2009 S. Karger AG, Basel
引用
收藏
页码:201 / 206
页数:6
相关论文
共 50 条
  • [41] Assessment of small nerve fiber function as an early marker of peripheral neuropathy in children and adolescents with type 1 diabetes mellitus (T1DM)
    Stavroula, Argyropoulou
    Panagiotis, Kokotis
    George, Paltoglou
    Chrysanthi, Boutziouka
    Georgia, Karamatzianni
    Spyridon, Karanasios
    Irine-Ikbale, Sakou
    Kyriaki, Karavanaki
    ENDOCRINE, 2025, 87 (01) : 116 - 125
  • [42] Health-related quality of life (HRQOL) and its associated factors in children with Type 1 Diabetes Mellitus (T1DM)
    Marta Murillo
    Joan Bel
    Jacobo Pérez
    Raquel Corripio
    Gemma Carreras
    Xavier Herrero
    Josep-Maria Mengibar
    Dolors Rodriguez-Arjona
    Ulrike Ravens-Sieberer
    Hein Raat
    Luis Rajmil
    BMC Pediatrics, 17
  • [43] Oral insulin for the prevention of diabetes in relatives at risk for type 1 diabetes mellitus (T1DM)
    Krischer, Jeffrey
    DIABETES, 2007, 56 : A699 - A699
  • [44] Plasma and urine CTGF and glycosaminoglycans levels in children and adolescents with type 1 diabetes mellitus (T1DM). A possible link to diabetic nephropathy
    Ellina, O.
    Chatzigeorgiou, A.
    Mylona-Karagianni, C.
    Tsouvalas, E.
    Lyberi, M.
    Kamper, E.
    FEBS JOURNAL, 2008, 275 : 236 - 236
  • [45] Assessment of small nerve fiber function as an early marker of peripheral neuropathy in children and adolescents with type 1 diabetes mellitus (T1DM)
    Kokotis, Panagiotis
    Paltoglou, George
    Argyropoulou, Stavroula
    Bountziouka, Chrysanthi
    Karamatzianni, Georgia
    Karanasios, Spyridon
    Sakou, Irini-Ikbale
    Karavanaki, Kyriaki
    HORMONE RESEARCH IN PAEDIATRICS, 2024, 97 : 164 - 164
  • [46] Diabetes management goals identified by families with children with type 1 diabetes (T1DM)
    Lochrie, Amanda
    Hood, Korey
    Wysocki, Tim
    Laffel, Lori
    Anderson, Barbara
    DIABETES, 2006, 55 : A426 - A426
  • [47] HDL EFFLUX CAPACITY, AND PARTICLE REMODELLING IN PATIENTS WITH TYPE 1 DIABETES MELLITUS (T1DM) AND TYPE 2 DIABETES MELLITUS (T2DM)
    Byrne, R.
    Curley, S.
    Ahmed, K.
    Ahmed, M.
    Gibney, J.
    Mcgillicuddy, F.
    ATHEROSCLEROSIS, 2020, 315 : E65 - E66
  • [48] Development of Multivalent Vaccine for Type 1 Diabetes Mellitus (T1DM) in NOD Mice
    Lin, M. S.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2009, 123 (02) : S15 - S15
  • [49] A CASE OF PREGABALIN INDUCED HYPOGLYCAEMIA IN A PATIENT WITH TYPE 1 DIABETES MELLITUS (T1DM)
    Phanse, Salonee
    David, Neesan
    Thin, Aye
    May, Stephen
    NEPHROLOGY, 2024, 29 : 73 - 74
  • [50] Autoimmune thyroid disease (ATD) in children with type 1 diabetes mellitus (T1DM): a review of 15 years
    Hadjiathanasiou, Charalambos
    Papathanasiou, Asteroula
    Kefalas, Nikolaos
    Petrou, Vassilios
    Anastasakou, Marina
    Papachilleos, Petros
    Paraskaki, Irini
    Karayanni, Christina
    HORMONE RESEARCH, 2006, 65 : 37 - 37